The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...

Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer Circulating tumor DNA (ctDNA) is increasingly being used to ...

A recent study on DNA microarray technology highlights its essential role in enabling high-throughput analysis of large numbers of genes through arrays of probes integrated on a solid-phase support.

Accurate diagnosis and classification of Central Nervous System (CNS) tumors, particularly meningiomas, pose significant challenges, especially when using DNA methylation profiling data. Limited ...

Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the launch of the sparQ™ ...

According to Coherent Market Insights, DNA Sequencing Market is estimated to be valued at USD 8,486.7 Mn in 2025 and is expected to reach USD 18,412.4 Mn in 2032, exhibiting a compound annual growth ...

The LineaDNA platform is a proprietary, cell-free DNA production system leveraging Applied DNA's deep expertise in large-scale PCR. Unlike conventional plasmid-based DNA production methods, the ...

STONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in synthetic DNA manufacturing powered by scalable PCR platforms ...